Allscripts Healthcare Solutions Inc (MDRX) is gearing up to be a turnaround story as new leadership recognizes the urgency to drive the integration of the Eclipsys acquisition, positioning MDRX well to compete in the market with its complementary hospital and physician businesses, says Charles Rhyee, Managing Director and Senior Research Analyst at Cowen and Company.
“The one that we’re really recommending is Allscripts. I think it’s a very interesting turnaround story. It’s one where you have new leadership. On paper it makes sense, because these are complementary businesses. Old management, I don’t think, recognized the urgency to drive the integration. I think new management has come in understanding that and is helping push that process along,” Rhyee said.
FOR MORE INFORMATION ABOUT THIS INTERVIEW CLICK HERE.
Allscripts was originally a maker of electronic health records for physician practices, and with the acquisition of Eclipsys now has exposure to the hospital market, Rhyee says, and an opportunity to turn its business around and compete in the marketplace.
“I think they have all the pieces to be successful. It’s a question of whether they have enough time to get it all together to become competitive. I think they do. And while I don’t think they have to be in the same league with Epic and Cerner (CERN), I do think this market is still diverse and broad enough that there’s room for more than two players,” Rhyee said.
dbMotion an “Achilles’ Heel” for Allscripts Health Solutions Inc (MDRX)
May 22, 2015
Justin Timberlake’s Southern Hospitality Aims for Fast-Casual Market
February 18, 2015
2018 Biotechnology Stock Winners from Top Research Analysts: Allscripts (NASDAQ:MDRX), Hologic (NASDAQ:HOLX), and Lexicon (NASDAQ:LXRX)
December 27, 2017
LeapFrog Enterprises, Inc.’s (LF) Learning Content Carves a Niche in Children’s Toys
June 07, 2013
Recommended Reading – Google’s CFO Search: Why’d it take so long?
June 27, 2008
